Previzion Aksyon Edito Medicine (EDIT)
Edito Medicine
Dernie pri$2.59Mizajou 25 Sep 2026 19:59 UTC
Chanjman-6.16%
Previzyon AI: EDIT
AI a pibliye yon pri objektif pou pwochen jou trading la, fen semenn nan ak fen mwa nan. Chanjman an mezire depi dènye pri a. Se estimasyon estatistik, se pa konsèy envestisman.
Pri lor dernie 6 mwa
Premium montre bann objektif pri AI pou 1 zour, 1 semenn ek 1 mwa pou sa aksyon la ek pou tou lot aksyon.
Debloke Premium🔒 Historik previzion
Historik previzion an — chak ansyen previzion bò kote klotir reyèl la — fè pati Premium.
Debloke PremiumSou Konpayi Sa a
Editas Medicine, Inc. is a biotechnology company that provides gene engineering services. The company develops genome editing technologies to create a platform for potential therapeutic agents and operates in the United States.
